Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01345305 · ClinicalTrials.gov registry record
Biomarker Development in Sturge-Weber Syndrome
A clinical trial, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Completed
- Registry status
- 40
- Enrollment target
NCT01345305 is a clinical trial that has completed, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 40 participants.
The verdict
NCT01345305 has completed, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This is a study of 40 individuals with Sturge-Weber Syndrome (SWS) brain and/or eye involvement. It will examine the test-retest reliability of the following clinical tests: 1. Quantitative EEG 2. Transcranial Doppler 3. Medical Rehabilitation Scales 4. Optical Coherence Tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01345305
The ClinicalTrials.gov registry entry for NCT01345305 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01345305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01345305 about?
NCT01345305 is a clinical study titled "Biomarker Development in Sturge-Weber Syndrome". This is a study of 40 individuals with Sturge-Weber Syndrome (SWS) brain and/or eye involvement. It will examine the test-retest reliability of the following clinical tests: 1. Quantitative EEG 2. Transcranial Doppler 3. Medical Rehabilitation Scales 4. Optical Coherence Tomography
What is the current status of trial NCT01345305?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2010-07. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT01345305?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.